Filter
1636
Filtered Results: 1636
Text search:
Femal
Health
Company
Featured
Recommendations
181
New Publications
462
Language
Document type
No document type
928
Studies & Reports
288
Guidelines
216
Manuals
96
Strategic & Response Plan
58
Training Material
22
Fact sheets
15
Situation Updates
5
Infographics
4
Brochures
3
App
1
Countries / Regions
Global
79
India
58
Nepal
37
Western and Central Europe
36
Liberia
29
Sierra Leone
28
Nigeria
28
Bangladesh
28
Myanmar / Burma
25
Kenya
23
South Africa
22
Asia
21
Ukraine
20
Rwanda
20
Ethiopia
20
Syria
19
Africa
19
Uganda
19
Latin America and the Carribbean
18
Zambia
18
Malawi
17
Philippines
17
Ghana
16
South–East Asia Region
16
Indonesia
16
Eastern Europe
15
Namibia
14
Mozambique
12
Tanzania
12
Germany
12
Congo, Democratic Republic of
12
Senegal
11
Yemen
10
South Sudan
10
Zimbabwe
9
Cambodia
9
Lesotho
8
Botswana
8
Guinea
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Moldova
6
Russia
6
North Macedonia
5
Cameroon
5
Afghanistan
5
China
4
Venezuela
4
Jordan
4
Middle East and North Africa
4
East and Southern Africa
4
Brazil
4
Sudan
4
Georgia
4
Somalia
4
Tajikistan
3
Serbia
3
Benin
3
Albania
3
Kyrgyzstan
3
Armenia
3
Haiti
3
West and Central Africa
3
Western Pacific Region
3
Paraguay
3
North America
3
Lebanon
3
Vietnam
3
Central African Republic
3
Libya
3
Iraq
3
Eswatini/ Swaziland
3
Colombia
2
Thailand
2
Kazakhstan
2
Uzbekistan
2
Peru
2
USA
2
Southern Africa
2
Papua New Guinea
2
Sri Lanka
2
Romania
2
Palestine
2
Poland
2
Mali
2
Madagascar
2
Pakistan
2
Timor Leste/ East Timor
1
Mexico
1
Turkey
1
Gambia
1
Togo
1
Iran
1
Laos
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Hungary
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Tunisia
1
Azerbaijan
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Egypt
1
Greece
1
Angola
1
Bhutan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
524
Clinical Guidelines
172
Women & Child Health
162
Public Health
123
Key Resources
97
Capacity Building
31
Pharmacy & Technologies
21
Toolboxes
HIV
193
Mental Health
97
COVID-19
80
NTDs
63
TB
57
Caregiver
56
Disability
54
Conflict
47
Ebola & Marburg
41
Planetary Health
40
Global Health Education
34
Refugee
30
Malaria
25
Zika
25
AMR
25
NCDs
24
Pharmacy
21
Natural Hazards
18
Rapid Response
17
Specific Hazards
14
Health Financing Toolbox
14
2.0 Rapid Response
7
Polio
7
Cholera
5
Social Ethics
4
This publication outlines public health aspects of alcohol use and harm in WHO South East Asia Region Countries. It summarizes Global Regional and country specific data and also discusses aspects of alcohol control that are important in the context of the Region. The possible future trend of alcohol...
WHO, in partnership with the International Society for Prosthetics and Orthotics (ISPO) and the United States Agency for International Development (USAID), has published global standards for prosthetics and orthotics. Its aim is to ensure that prosthetics and orthotics services are people-centred an...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
second edition
The recommendations in this guideline are intended to inform the development of relevant national- and local-level health policies and clinical protocols. Therefore, the target audience includes national and local public health policy-makers, implementers and managers of maternal and child health pr...
